Ascend Advanced Therapies
PrivateLast Round
Strategic
Nov 12, 2024
Total Funding Raised
$263.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Ascend Advanced Therapies operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Strategic round in November 2024.
Ascend Advanced Therapies is a biotechnology company that provides contract development and manufacturing services for gene and cell therapy developers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ascend Advanced Therapies Comparables
Compare Ascend Advanced Therapies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Andelyn Biosciences | 90% | |
| Advanced Medicine Partners | 84% | |
| Ajinomoto Co. Inc | 81% |
For institutional investors. Book with your work email.
Ascend Advanced Therapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Nov 12, 2024 | ||||
| Series A | Mar 20, 2023 | ||||
| Seed | Jun 22, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ascend Advanced Therapies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cathay Capital | Series A, Strategic |
| Deerfield Management | Series A, Strategic |
| EW Healthcare Partners | Strategic |
| Digitalis Ventures | Series A, Strategic |
| DCVC Bio | Series A, Strategic |
| 4BIO Capital | Series A, Strategic |
| Ajinomoto Co., Inc. | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 38% MoM.
For institutional investors. Book with your work email.
Ascend Advanced Therapies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ascend Advanced Therapies's valuation, stock price, and market status.
Is Ascend Advanced Therapies a public or private company?
Ascend Advanced Therapies is a private company.
What is the current stock price of Ascend Advanced Therapies?
Ascend Advanced Therapies is a private company, so its shares have no public market price. Caplight tracks Ascend Advanced Therapies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ascend Advanced Therapies worth (valuation)?
Valuation information for Ascend Advanced Therapies is not publicly available.
Can I buy Ascend Advanced Therapies stock?
Ascend Advanced Therapies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ascend Advanced Therapies's last funding round?
Ascend Advanced Therapies's most recent funding round was Strategic on November 12, 2024.
Who are the main investors in Ascend Advanced Therapies?
Key investors in Ascend Advanced Therapies include EW Healthcare Partners, Monograph Capital, Abingworth.
Will Ascend Advanced Therapies IPO soon?
No public IPO plans have been announced for Ascend Advanced Therapies.
How can I track Ascend Advanced Therapies secondary market activity?
Caplight tracks bids, offers, and trades in Ascend Advanced Therapies's shares on secondary markets.